United States
US 12,702,712 B2
Enteroendocrine cell-targeting polymer substance conjugated with photosensitizer, and medical use thereof for ameliorating metabolic disease
US 12,702,712 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: The Catholic University of Korea Industry-Academic Cooperation Foundation. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- The Catholic University of Korea Industry-Academic Cooperation Foundation
- Inventors
- Kun NA; Sang Hee LEE
- Publication date
- 2026-08-11
- Filing date
- 2022-11-18
- Document type
- B2 Granted patent
- Also written as
- US 12,702,712 B2 · US12702712 · 12702712
Abstract
A fatty acid-biocompatible polymer-photosensitizer conjugate is provided. The conjugate can kill GIP-secreting cells by generating active oxygen upon irradiation with light, and has the effect of increasing insulin, and thus can be effectively used for ameliorating and treating metabolic diseases such as obesity and diabetes.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free